Company Filing History:
Years Active: 2020-2025
Title: Christoph Schumacher: Innovator in Pharmaceutical Chemistry
Introduction
Christoph Schumacher is a notable inventor based in Walchwil, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address aldosterone-related disorders. With a total of 4 patents to his name, Schumacher's work is recognized for its potential impact on medical treatments.
Latest Patents
Schumacher's latest patents include innovative compounds aimed at treating diseases associated with aldosterone overexposure. One of his key inventions is an aldosterone synthase inhibitor, which involves a compound selected from (R)-(+)-5-(p-cyanophenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine and its pharmaceutically acceptable salts. This invention emphasizes the phosphate salt of the compound, which is designed to have an enantiomeric excess of the (R) form greater than or equal to 97%. The patent also details pharmaceutical compositions that utilize this compound for treating various diseases and disorders in humans, including women of childbearing potential and pediatric patients.
Another significant patent by Schumacher is for R-fadrozole, which is intended for the treatment of aldosteronism. This composition comprises (R)-(+)-5-(p-cyanophenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine or its pharmaceutically acceptable salts. The invention outlines a daily administration regimen for patients suffering from diseases where aldosterone overexposure exacerbates symptoms.
Career Highlights
Christoph Schumacher is associated with Damian Pharma AG, where he continues to innovate in the pharmaceutical sector. His work is characterized by a strong focus on developing effective treatments for conditions linked to hormonal imbalances.
Collaborations
Schumacher collaborates with esteemed colleagues, including Ronald E. Steele and Walter Fuhrer, contributing to a dynamic research environment that fosters innovation and advancement in pharmaceutical sciences.
Conclusion
Christoph Schumacher's contributions to pharmaceutical chemistry, particularly in the realm of aldosterone-related treatments, highlight his role as a significant inventor in the field. His patents reflect a commitment to improving medical outcomes for patients affected by hormonal disorders.